Olema Pharmaceuticals, Inc.·4

Feb 3, 7:05 PM ET

Moriarty John B 4

4 · Olema Pharmaceuticals, Inc. · Filed Feb 3, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
Moriarty John B
EVP, Ch. Legal Officer & Sec.
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-01+166,250166,250 total
    Exercise: $7.02Exp: 2032-01-31Common Stock (166,250 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    form4-02032022_040246.xmlPrimary